Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Increased expression of osteopontin in patients with triple-negative breast cancer.

European journal of clinical investigation - 1 Jun 2008

Wang X, Chao L, Ma G, Chen L, Tian B, Zang Y, Sun J

Abstract excerpt

BACKGROUND: Patients with triple-negative [oestrogen receptor (ER) negative, progesterone receptor (PR) negative, and human epidermal growth factor receptor 2 (HER-2/neu) negative] breast cancer, accounting for about 15% of breast cancer cases, are associated with aggressive histology, poor prognosis and shorter survival. Osteopontin is a chemokine-like phosphorylated glycoprotein that plays important role in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Databases, Factual
Share to Disease-Free Survival
Share to Lymphatic Metastasis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Osteopontin

Share to Proportional Hazards Models

Share to Receptor, ErbB-2

Share to Receptors, Estrogen

Share to Receptors, Progesterone

Source

Identifiers

PMID: 18452545
DOI: 10.1111/j.1365-2362.2008.01956.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Increased expression of osteopontin in patients with triple-negative breast cancer.PMID 18452545Read ↗

Osteopontin induces multiple changes in gene expression that reflect the six “hallmarks of cancer” in a model of breast cancer progressionSemantic proximity Read ↗

Human osteopontin: Potential clinical applications in cancer (Review)Semantic proximity Read ↗

Osteopontin splice variants expressed by breast tumors regulate monocyte activation via MCP-1 and TGF-β1.Semantic proximity Read ↗

Role of osteopontin in the pathophysiology of cancerSemantic proximity Read ↗

The role of Osteopontin in tumor metastasis.Semantic proximity Read ↗

Primary breast carcinoma: association of mammographic calcifications with osteopontin expression.Semantic proximity Read ↗

Osteopontin up-regulates critical epithelial-mesenchymal transition transcription factors to induce an aggressive breast cancer phenotype.Semantic proximity Read ↗

An osteopontin promoter polymorphism is associated with aggressiveness in breast cancer.Semantic proximity Read ↗

Osteopontin: role in cell signaling and cancer progressionSemantic proximity Read ↗

An osteopontin splice variant induces anchorage independence in human breast cancer cells.Semantic proximity Read ↗

Osteopontin-c Splicing Isoform Contributes to Ovarian Cancer ProgressionSemantic proximity Read ↗

Role of osteopontin in cellular signaling and metastatic phenotype.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.